<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01931839</url>
  </required_header>
  <id_info>
    <org_study_id>VX12-809-105</org_study_id>
    <nct_id>NCT01931839</nct_id>
  </id_info>
  <brief_title>A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis</brief_title>
  <official_title>A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vertex Pharmaceuticals Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vertex Pharmaceuticals Incorporated</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of long-term treatment with
      lumacaftor in combination with ivacaftor in people 12 years and older with Cystic Fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase 3, parallel group, multicenter, rollover study in participants with CF who
      are homozygous or heterozygous for the F508del CFTR mutation and who previously participated
      in Study 103 (Study VX12-809-103, NCT01807923), Study 104 (Study VX12-809-104, NCT01807949),
      or Cohort 4 of Study 102 (Study VX09-809-102, NCT01225211).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Part A Treatment Cohort: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>Day 1 up to Week 105 (Study 105)</time_frame>
    <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Part B Treatment Cohort: Number of Participants With Treatment-Emergent AEs and SAEs</measure>
    <time_frame>Day 1 up to Week 105 (Study 105)</time_frame>
    <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) At Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 103/104/105); Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Absolute Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Absolute Change From Baseline in Body Mass Index (BMI) at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>BMI = (Weight in kilogram [kg]) divided by (Stature in meters [m]) ^2. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Absolute Change From Baseline in BMI at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
    <description>BMI = (Weight [in kg]) divided by (Stature [in meters]) ^2. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Number of Pulmonary Exacerbations Events Per Patient-Year</measure>
    <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
    <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. The number of events per patient year were reported, where patient years = total number of days on study/336. Analysis includes all events in the Cumulative Study Period for Arm 1 and 3, and all events in the Current Study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Absolute Change From Baseline in Cystic Fibrosis Questionnaire - Revised (CFQ-R) Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</measure>
    <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 48, 72 (Study 105)</time_frame>
    <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</measure>
    <time_frame>Baseline (Study 102 Study), Day 15, Week 8, 16, 24, 48, 72 (Study 105)</time_frame>
    <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Absolute Change From Baseline in BMI Z-score at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
    <description>z-score is a statistical measure to evaluate how a single data point compares to a standard. It describes whether a mean was above or below the standard and how unusual the measurement is with range from -infinity to +infinity; 0: same mean, &gt;0: a greater mean, and &lt;0: a lesser mean than the standard. BMI-for-age z-score was calculated by using centers for disease control and prevention (CDC) growth charts for the pediatric population. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
    <description>Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</measure>
    <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
    <description>Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Time-to-First Pulmonary Exacerbation</measure>
    <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
    <description>Time-to-first pulmonary exacerbation was analyzed using the Kaplan-Meier estimates. Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Percentage of Participants With at Least 1 Pulmonary Exacerbation</measure>
    <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
    <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</measure>
    <time_frame>Baseline (Study 103/104/105); Day 15, Week 8, 16, 24, 36, 48, 60, 72, 84, 96 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% and 10% relative change in percent predicted FEV1 from baseline were reported. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part B Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</measure>
    <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
    <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% relative change in percent predicted FEV1 from Baseline were reported. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7. As per planned analysis, endpoint evaluation included subjects from the parent study VX09-809-102 as well.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Part A Observation Cohort: Number of Participants With Serious Adverse Events (SAEs)</measure>
    <time_frame>up to 2 years</time_frame>
    <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after the informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event.</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">1164</enrollment>
  <condition>Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation</condition>
  <arm_group>
    <arm_group_label>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received lumacaftor (LUM, VX-809) 600 milligram (mg) plus ivacaftor (IVA, VX-770) 250 mg fixed-dose combination (FDC) tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 or VX12-809-104, and will receive the same treatment in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, and will receive LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 or VX12-809-104, and will receive the same treatment in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, and will receive LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 5 Part A: Observational Cohort</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants who received either LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening OR LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening OR placebo matched to LUM and IVA in the morning and evening, in the previous study VX12-809-103 or VX12-809-104, and will be observed (will not receive study drug) in this study VX12-809-105 for up to 2 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102, and will receive the same treatment in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102, and will receive LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lumacaftor Plus Ivacaftor Combination</intervention_name>
    <description>Fixed dose combination tablet, oral use</description>
    <arm_group_label>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivacaftor</intervention_name>
    <description>Film-coated tablet, oral use</description>
    <arm_group_label>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
    <arm_group_label>Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent form (ICF), and where appropriate, signed assent form.

          -  Participants entering the Part A Treatment Cohort: Completed 24 weeks of study drug
             treatment in Study 103 or Study 104 and elect to enroll in Part A treatment cohort.

          -  Participants entering the Part B Treatment Cohort: Completed 56 days of study drug
             treatment in Cohort 4 of Study 102 and elect to enroll in Part B treatment cohort.

          -  Participants entering the Part A Observational Cohort: Completed 24 weeks of study
             drug treatment in Study 103 or Study 104, but do not elect to enroll in the Part A
             Treatment Cohort or do not qualify to enroll in Part A treatment cohort.

          -  Willing to remain on a stable CF medication regimen through the end of study (Part A
             and Part B Treatment Cohorts only).

        Exclusion Criteria:

          -  Any comorbidity or laboratory abnormality that, in the opinion of the investigator,
             might confound the results of the study or pose an additional risk in administering
             study drug to the participant (e.g., cirrhosis with portal hypertension).

          -  Pregnant and nursing females. Females of childbearing potential must have a negative
             pregnancy test at the Day 1 Visit.

          -  History of drug intolerance in the prior study that would pose an additional risk to
             the participant in the opinion of investigator or Vertex.

          -  History of poor compliance with study drug and/or procedures in the previous study as
             deemed by the investigator.

          -  Participation in an investigational drug trial (including studies investigating
             lumacaftor and/or ivacaftor, or studies requiring blood collections with or without
             administration of study drug)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Longbeach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madera</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Altamonte Springs</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Portland</city>
        <state>Maine</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bedford</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Long Branch</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charelston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Lambton Heights</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Adelaide</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chermside</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nedlands</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Subiaco</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wels</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ottowa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brno</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Plzeň - Bory</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha 5</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Strasbourg</city>
        <state>Bas Rhin</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marseille</city>
        <state>Bouches-du-Rhone</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toulouse</city>
        <state>Haute Garonne</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lille</city>
        <state>Nord</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bron Cedex</city>
        <state>Rhone</state>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pierre Benite</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rhone</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roscoff</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Muenchen</city>
        <state>Bayem</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Muenchen</city>
        <state>Bayern</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erlangen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Giessen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Koeln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Muenchen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tuebingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wuerzburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Genova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goteborg</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belfast</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2013</study_first_submitted>
  <study_first_submitted_qc>August 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2013</study_first_posted>
  <results_first_submitted>April 3, 2017</results_first_submitted>
  <results_first_submitted_qc>April 3, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 12, 2017</results_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ivacaftor</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study conducted in 2 parts: A &amp; B. Part A consisted of Treatment Cohorts &amp; Observational Cohort, which enrolled participants from Study VX12-809-103 (Study 103, NCT01807923) &amp; Study VX12-809-104 (Study 104, NCT01807949). Part B consisted of Treatment Cohorts which enrolled participants from Cohort 4 of Study VX09-809-102 (Study 102, NCT01225211).</recruitment_details>
      <pre_assignment_details>Of 1164 participants enrolled, 1163 were dosed and included in this study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received lumacaftor (LUM, VX-809) 600 milligram (mg) plus ivacaftor (IVA, VX-770) 250 mg fixed-dose combination (FDC) tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="P2">
          <title>Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="P3">
          <title>Arm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="P4">
          <title>Arm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="P5">
          <title>Arm 5 Part A: Observational Cohort</title>
          <description>Participants who received either LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening OR LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening OR placebo matched to LUM and IVA in the morning and evening, in the previous study VX12-809-103 or VX12-809-104, were observed (did not receive study drug) in this study VX12-809-105 for up to 2 years.</description>
        </group>
        <group group_id="P6">
          <title>Arm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="P7">
          <title>Arm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="335"/>
                <participants group_id="P2" count="178"/>
                <participants group_id="P3" count="340"/>
                <participants group_id="P4" count="176"/>
                <participants group_id="P5" count="19"/>
                <participants group_id="P6" count="55"/>
                <participants group_id="P7" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Full Analysis Set (As Randomized)</title>
              <participants_list>
                <participants group_id="P1" count="334"/>
                <participants group_id="P2" count="179"/>
                <participants group_id="P3" count="340"/>
                <participants group_id="P4" count="176"/>
                <participants group_id="P5" count="19"/>
                <participants group_id="P6" count="55"/>
                <participants group_id="P7" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Analysis Set (As Dosed)</title>
              <participants_list>
                <participants group_id="P1" count="335"/>
                <participants group_id="P2" count="178"/>
                <participants group_id="P3" count="340"/>
                <participants group_id="P4" count="176"/>
                <participants group_id="P5" count="19"/>
                <participants group_id="P6" count="55"/>
                <participants group_id="P7" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="294"/>
                <participants group_id="P2" count="152"/>
                <participants group_id="P3" count="301"/>
                <participants group_id="P4" count="162"/>
                <participants group_id="P5" count="18"/>
                <participants group_id="P6" count="50"/>
                <participants group_id="P7" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="39"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="5"/>
                <participants group_id="P7" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal of consent</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal of consent (not due to AE)</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Safety Set (study 105) included all participants who were exposed to any amount of study drug.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received lumacaftor (LUM, VX-809) 600 milligram (mg) plus ivacaftor (IVA, VX-770) 250 mg fixed-dose combination (FDC) tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B2">
          <title>q12h Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B3">
          <title>Arm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B4">
          <title>Arm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B5">
          <title>Arm 5 Part A: Observational Cohort</title>
          <description>Participants who received either LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening OR LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening OR placebo matched to LUM and IVA in the morning and evening, in the previous study VX12-809-103 or VX12-809-104, were observed (did not receive study drug) in this study VX12-809-105 for up to 2 years.</description>
        </group>
        <group group_id="B6">
          <title>Arm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B7">
          <title>Arm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="B8">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="335"/>
            <count group_id="B2" value="178"/>
            <count group_id="B3" value="340"/>
            <count group_id="B4" value="176"/>
            <count group_id="B5" value="19"/>
            <count group_id="B6" value="55"/>
            <count group_id="B7" value="60"/>
            <count group_id="B8" value="1163"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>12 years to less than 18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="94"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greater than or equal to 18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="242"/>
                    <measurement group_id="B2" value="131"/>
                    <measurement group_id="B3" value="246"/>
                    <measurement group_id="B4" value="129"/>
                    <measurement group_id="B5" value="17"/>
                    <measurement group_id="B6" value="55"/>
                    <measurement group_id="B7" value="60"/>
                    <measurement group_id="B8" value="880"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="164"/>
                    <measurement group_id="B4" value="86"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="25"/>
                    <measurement group_id="B7" value="31"/>
                    <measurement group_id="B8" value="573"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="169"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="176"/>
                    <measurement group_id="B4" value="90"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="30"/>
                    <measurement group_id="B7" value="29"/>
                    <measurement group_id="B8" value="590"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Part A Treatment Cohort: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)</title>
        <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
        <time_frame>Day 1 up to Week 105 (Study 105)</time_frame>
        <population>Safety Set (study 105) included all participants in Treatment Cohort Part A who were exposed to any amount of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)</title>
          <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
          <population>Safety Set (study 105) included all participants in Treatment Cohort Part A who were exposed to any amount of study drug.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="335"/>
                <count group_id="O2" value="178"/>
                <count group_id="O3" value="340"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants with any AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="331"/>
                    <measurement group_id="O2" value="177"/>
                    <measurement group_id="O3" value="333"/>
                    <measurement group_id="O4" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants with SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                    <measurement group_id="O2" value="77"/>
                    <measurement group_id="O3" value="143"/>
                    <measurement group_id="O4" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Part B Treatment Cohort: Number of Participants With Treatment-Emergent AEs and SAEs</title>
        <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
        <time_frame>Day 1 up to Week 105 (Study 105)</time_frame>
        <population>Safety Set (study 105) included all participants in the Treatment Cohort Part B who were exposed to any amount of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Number of Participants With Treatment-Emergent AEs and SAEs</title>
          <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event. Any AE that increased in severity or newly developed at or after initial dosing of study drug was considered treatment-emergent.</description>
          <population>Safety Set (study 105) included all participants in the Treatment Cohort Part B who were exposed to any amount of study drug.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Participants with AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Participants with SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) At Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105); Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>Full Analysis Set (FAS) study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) At Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>Full Analysis Set (FAS) study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>percent predicted of FEV1</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="319"/>
                <count group_id="O2" value="173"/>
                <count group_id="O3" value="317"/>
                <count group_id="O4" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="319"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="317"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="0.5"/>
                    <measurement group_id="O2" value="2.8" spread="0.6"/>
                    <measurement group_id="O3" value="2.8" spread="0.5"/>
                    <measurement group_id="O4" value="3" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="309"/>
                    <count group_id="O2" value="164"/>
                    <count group_id="O3" value="316"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="0.5"/>
                    <measurement group_id="O2" value="2.8" spread="0.6"/>
                    <measurement group_id="O3" value="3.4" spread="0.5"/>
                    <measurement group_id="O4" value="4.2" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="307"/>
                    <count group_id="O2" value="166"/>
                    <count group_id="O3" value="313"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="0.5"/>
                    <measurement group_id="O2" value="2.7" spread="0.6"/>
                    <measurement group_id="O3" value="2.5" spread="0.5"/>
                    <measurement group_id="O4" value="3.6" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="291"/>
                    <count group_id="O2" value="158"/>
                    <count group_id="O3" value="295"/>
                    <count group_id="O4" value="154"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="0.5"/>
                    <measurement group_id="O2" value="2.4" spread="0.6"/>
                    <measurement group_id="O3" value="2.7" spread="0.5"/>
                    <measurement group_id="O4" value="3.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="292"/>
                    <count group_id="O2" value="155"/>
                    <count group_id="O3" value="294"/>
                    <count group_id="O4" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="0.5"/>
                    <measurement group_id="O2" value="2.2" spread="0.7"/>
                    <measurement group_id="O3" value="1.9" spread="0.5"/>
                    <measurement group_id="O4" value="3.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="279"/>
                    <count group_id="O2" value="153"/>
                    <count group_id="O3" value="286"/>
                    <count group_id="O4" value="143"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.5"/>
                    <measurement group_id="O2" value="1.8" spread="0.7"/>
                    <measurement group_id="O3" value="1.4" spread="0.5"/>
                    <measurement group_id="O4" value="2.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="276"/>
                    <count group_id="O2" value="146"/>
                    <count group_id="O3" value="282"/>
                    <count group_id="O4" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.5"/>
                    <measurement group_id="O2" value="2.1" spread="0.7"/>
                    <measurement group_id="O3" value="1.6" spread="0.5"/>
                    <measurement group_id="O4" value="1.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="275"/>
                    <count group_id="O2" value="146"/>
                    <count group_id="O3" value="273"/>
                    <count group_id="O4" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.5"/>
                    <measurement group_id="O2" value="1.9" spread="0.7"/>
                    <measurement group_id="O3" value="0.5" spread="0.5"/>
                    <measurement group_id="O4" value="1.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Absolute Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
        <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Absolute Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
          <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>percent predicted of FEV1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="8"/>
                    <measurement group_id="O2" value="-3.4" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="55"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.9" spread="7.4"/>
                    <measurement group_id="O2" value="-1.8" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.1" spread="9"/>
                    <measurement group_id="O2" value="-2.8" spread="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="7.7"/>
                    <measurement group_id="O2" value="-2.5" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="7.9"/>
                    <measurement group_id="O2" value="-2.3" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.4" spread="11.2"/>
                    <measurement group_id="O2" value="-2" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="10.1"/>
                    <measurement group_id="O2" value="-1.9" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="9.2"/>
                    <measurement group_id="O2" value="-7.8" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>percent change</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="319"/>
                <count group_id="O2" value="173"/>
                <count group_id="O3" value="317"/>
                <count group_id="O4" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Relative Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="319"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="317"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="0.9"/>
                    <measurement group_id="O2" value="5.1" spread="1.2"/>
                    <measurement group_id="O3" value="5.3" spread="0.9"/>
                    <measurement group_id="O4" value="4.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="309"/>
                    <count group_id="O2" value="164"/>
                    <count group_id="O3" value="316"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="0.9"/>
                    <measurement group_id="O2" value="5.6" spread="1.2"/>
                    <measurement group_id="O3" value="6.2" spread="0.9"/>
                    <measurement group_id="O4" value="7.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="307"/>
                    <count group_id="O2" value="166"/>
                    <count group_id="O3" value="313"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="0.9"/>
                    <measurement group_id="O2" value="5.4" spread="1.2"/>
                    <measurement group_id="O3" value="4.8" spread="0.9"/>
                    <measurement group_id="O4" value="6.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="291"/>
                    <count group_id="O2" value="158"/>
                    <count group_id="O3" value="295"/>
                    <count group_id="O4" value="154"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="0.9"/>
                    <measurement group_id="O2" value="4.9" spread="1.2"/>
                    <measurement group_id="O3" value="5" spread="0.9"/>
                    <measurement group_id="O4" value="6.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="292"/>
                    <count group_id="O2" value="155"/>
                    <count group_id="O3" value="294"/>
                    <count group_id="O4" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="0.9"/>
                    <measurement group_id="O2" value="4" spread="1.2"/>
                    <measurement group_id="O3" value="3.6" spread="0.9"/>
                    <measurement group_id="O4" value="5.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="279"/>
                    <count group_id="O2" value="153"/>
                    <count group_id="O3" value="286"/>
                    <count group_id="O4" value="143"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="0.9"/>
                    <measurement group_id="O2" value="3.6" spread="1.2"/>
                    <measurement group_id="O3" value="2.9" spread="0.9"/>
                    <measurement group_id="O4" value="3.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="276"/>
                    <count group_id="O2" value="146"/>
                    <count group_id="O3" value="282"/>
                    <count group_id="O4" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="0.9"/>
                    <measurement group_id="O2" value="4.1" spread="1.2"/>
                    <measurement group_id="O3" value="2.7" spread="0.9"/>
                    <measurement group_id="O4" value="3.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="275"/>
                    <count group_id="O2" value="146"/>
                    <count group_id="O3" value="273"/>
                    <count group_id="O4" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="0.9"/>
                    <measurement group_id="O2" value="3.8" spread="1.2"/>
                    <measurement group_id="O3" value="1.4" spread="0.9"/>
                    <measurement group_id="O4" value="2.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
        <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Relative Change From Baseline in Percent Predicted FEV1 at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). The Hankinson standard was used for male participants 18 years and older and female participants 16 years and older. The Wang standard was used for male participants aged 12 to 17 years and for female participants aged 12 to 15 years. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
          <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>percent change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Relative Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="13.6"/>
                    <measurement group_id="O2" value="-5.8" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="55"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.2" spread="12.8"/>
                    <measurement group_id="O2" value="-3.1" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="50"/>
                    <count group_id="O2" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="15.8"/>
                    <measurement group_id="O2" value="-4.9" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="36"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.4" spread="13.2"/>
                    <measurement group_id="O2" value="-4.2" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.1" spread="12.5"/>
                    <measurement group_id="O2" value="-3.5" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.9" spread="15.9"/>
                    <measurement group_id="O2" value="-2.8" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="16.6"/>
                    <measurement group_id="O2" value="-2.6" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Relative Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.3" spread="13.3"/>
                    <measurement group_id="O2" value="-11.8" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Absolute Change From Baseline in Body Mass Index (BMI) at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>BMI = (Weight in kilogram [kg]) divided by (Stature in meters [m]) ^2. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Absolute Change From Baseline in Body Mass Index (BMI) at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>BMI = (Weight in kilogram [kg]) divided by (Stature in meters [m]) ^2. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>Kilogram per square meter (kg/m^2)</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="329"/>
                <count group_id="O2" value="178"/>
                <count group_id="O3" value="338"/>
                <count group_id="O4" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="328"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="338"/>
                    <count group_id="O4" value="175"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.56" spread="0.06"/>
                    <measurement group_id="O2" value="0.06" spread="0.08"/>
                    <measurement group_id="O3" value="0.5" spread="0.06"/>
                    <measurement group_id="O4" value="0.1" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="329"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="331"/>
                    <count group_id="O4" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.06"/>
                    <measurement group_id="O2" value="0.14" spread="0.08"/>
                    <measurement group_id="O3" value="0.55" spread="0.06"/>
                    <measurement group_id="O4" value="0.27" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="325"/>
                    <count group_id="O4" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.06"/>
                    <measurement group_id="O2" value="0.19" spread="0.08"/>
                    <measurement group_id="O3" value="0.53" spread="0.06"/>
                    <measurement group_id="O4" value="0.35" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="312"/>
                    <count group_id="O2" value="169"/>
                    <count group_id="O3" value="319"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" spread="0.06"/>
                    <measurement group_id="O2" value="0.22" spread="0.08"/>
                    <measurement group_id="O3" value="0.62" spread="0.06"/>
                    <measurement group_id="O4" value="0.41" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="304"/>
                    <count group_id="O2" value="165"/>
                    <count group_id="O3" value="315"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="0.06"/>
                    <measurement group_id="O2" value="0.33" spread="0.08"/>
                    <measurement group_id="O3" value="0.72" spread="0.06"/>
                    <measurement group_id="O4" value="0.59" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="299"/>
                    <count group_id="O2" value="162"/>
                    <count group_id="O3" value="307"/>
                    <count group_id="O4" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="0.06"/>
                    <measurement group_id="O2" value="0.42" spread="0.08"/>
                    <measurement group_id="O3" value="0.71" spread="0.06"/>
                    <measurement group_id="O4" value="0.62" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="296"/>
                    <count group_id="O2" value="158"/>
                    <count group_id="O3" value="298"/>
                    <count group_id="O4" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.71" spread="0.06"/>
                    <measurement group_id="O2" value="0.54" spread="0.08"/>
                    <measurement group_id="O3" value="0.8" spread="0.06"/>
                    <measurement group_id="O4" value="0.62" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="287"/>
                    <count group_id="O2" value="152"/>
                    <count group_id="O3" value="289"/>
                    <count group_id="O4" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="0.06"/>
                    <measurement group_id="O2" value="0.52" spread="0.08"/>
                    <measurement group_id="O3" value="0.69" spread="0.06"/>
                    <measurement group_id="O4" value="0.62" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Absolute Change From Baseline in BMI at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>BMI = (Weight [in kg]) divided by (Stature [in meters]) ^2. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
        <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60 , 72 (Study 105)</time_frame>
        <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Absolute Change From Baseline in BMI at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>BMI = (Weight [in kg]) divided by (Stature [in meters]) ^2. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
          <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.52"/>
                    <measurement group_id="O2" value="-0.03" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.82"/>
                    <measurement group_id="O2" value="0.14" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="1.02"/>
                    <measurement group_id="O2" value="0.2" spread="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.92"/>
                    <measurement group_id="O2" value="0.14" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.54"/>
                    <measurement group_id="O2" value="0.85" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.64"/>
                    <measurement group_id="O2" value="0.81" spread="1.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.7"/>
                    <measurement group_id="O2" value="0.58" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.71"/>
                    <measurement group_id="O2" value="0.41" spread="1.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Number of Pulmonary Exacerbations Events Per Patient-Year</title>
        <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. The number of events per patient year were reported, where patient years = total number of days on study/336. Analysis includes all events in the Cumulative Study Period for Arm 1 and 3, and all events in the Current Study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
        <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
        <population>FAS (Study 103/104) was used for Arm 1 &amp; 3, &amp; included all participants randomized in previous studies &amp; dosed. FAS (Study 105) was used for Arm 2 &amp; 4, &amp; included all participants randomized in Part A Treatment Cohort &amp; dosed in current study 105. ‘Number Analyzed’=those participants who were evaluable at specified time points for each arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Number of Pulmonary Exacerbations Events Per Patient-Year</title>
          <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. The number of events per patient year were reported, where patient years = total number of days on study/336. Analysis includes all events in the Cumulative Study Period for Arm 1 and 3, and all events in the Current Study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
          <population>FAS (Study 103/104) was used for Arm 1 &amp; 3, &amp; included all participants randomized in previous studies &amp; dosed. FAS (Study 105) was used for Arm 2 &amp; 4, &amp; included all participants randomized in Part A Treatment Cohort &amp; dosed in current study 105. ‘Number Analyzed’=those participants who were evaluable at specified time points for each arm.</population>
          <units>events per patient year</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="368"/>
                <count group_id="O2" value="179"/>
                <count group_id="O3" value="369"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.38" lower_limit="0.32" upper_limit="0.46"/>
                    <measurement group_id="O2" value="0.42" lower_limit="0.33" upper_limit="0.54"/>
                    <measurement group_id="O3" value="0.32" lower_limit="0.26" upper_limit="0.38"/>
                    <measurement group_id="O4" value="0.37" lower_limit="0.29" upper_limit="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Absolute Change From Baseline in Cystic Fibrosis Questionnaire – Revised (CFQ-R) Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</title>
        <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 48, 72 (Study 105)</time_frame>
        <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Absolute Change From Baseline in Cystic Fibrosis Questionnaire – Revised (CFQ-R) Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</title>
          <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="324"/>
                <count group_id="O2" value="174"/>
                <count group_id="O3" value="325"/>
                <count group_id="O4" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="324"/>
                    <count group_id="O2" value="174"/>
                    <count group_id="O3" value="325"/>
                    <count group_id="O4" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="0.9"/>
                    <measurement group_id="O2" value="2.3" spread="1.2"/>
                    <measurement group_id="O3" value="6.2" spread="0.9"/>
                    <measurement group_id="O4" value="3.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="323"/>
                    <count group_id="O2" value="164"/>
                    <count group_id="O3" value="319"/>
                    <count group_id="O4" value="166"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="0.9"/>
                    <measurement group_id="O2" value="4.1" spread="1.2"/>
                    <measurement group_id="O3" value="5.1" spread="0.9"/>
                    <measurement group_id="O4" value="6.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="313"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="312"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.9"/>
                    <measurement group_id="O2" value="2.8" spread="1.2"/>
                    <measurement group_id="O3" value="6.4" spread="0.9"/>
                    <measurement group_id="O4" value="7" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="305"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="304"/>
                    <count group_id="O4" value="155"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="0.9"/>
                    <measurement group_id="O2" value="3.8" spread="1.2"/>
                    <measurement group_id="O3" value="6.1" spread="0.9"/>
                    <measurement group_id="O4" value="4.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="290"/>
                    <count group_id="O2" value="152"/>
                    <count group_id="O3" value="290"/>
                    <count group_id="O4" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="0.9"/>
                    <measurement group_id="O2" value="3.1" spread="1.3"/>
                    <measurement group_id="O3" value="3.7" spread="0.9"/>
                    <measurement group_id="O4" value="1.5" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="265"/>
                    <count group_id="O2" value="141"/>
                    <count group_id="O3" value="269"/>
                    <count group_id="O4" value="135"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="0.9"/>
                    <measurement group_id="O2" value="3.3" spread="1.3"/>
                    <measurement group_id="O3" value="5.7" spread="0.9"/>
                    <measurement group_id="O4" value="3.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</title>
        <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
        <time_frame>Baseline (Study 102 Study), Day 15, Week 8, 16, 24, 48, 72 (Study 105)</time_frame>
        <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Absolute Change From Baseline in CFQ-R Respiratory Domain Score at Day 15, Week 8, 16, 24, 48 and 72</title>
          <description>The CFQ-R is a validated participant-reported outcome measuring health-related quality of life for participants with cystic fibrosis. Respiratory domain assessed respiratory symptoms (for example, coughing, congestion, wheezing), the scaled score range: 0-100; higher scores indicating fewer symptoms and better health-related quality of life. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
          <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="18"/>
                    <measurement group_id="O2" value="-4.1" spread="18.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="18.6"/>
                    <measurement group_id="O2" value="1" spread="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="17.2"/>
                    <measurement group_id="O2" value="-0.2" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="19.1"/>
                    <measurement group_id="O2" value="-1.2" spread="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="14"/>
                    <measurement group_id="O2" value="4.9" spread="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="21.8"/>
                    <measurement group_id="O2" value="2.2" spread="18.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Absolute Change From Baseline in BMI Z-score at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>z-score is a statistical measure to evaluate how a single data point compares to a standard. It describes whether a mean was above or below the standard and how unusual the measurement is with range from -infinity to +infinity; 0: same mean, &gt;0: a greater mean, and &lt;0: a lesser mean than the standard. BMI-for-age z-score was calculated by using centers for disease control and prevention (CDC) growth charts for the pediatric population. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
        <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Absolute Change From Baseline in BMI Z-score at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>z-score is a statistical measure to evaluate how a single data point compares to a standard. It describes whether a mean was above or below the standard and how unusual the measurement is with range from -infinity to +infinity; 0: same mean, &gt;0: a greater mean, and &lt;0: a lesser mean than the standard. BMI-for-age z-score was calculated by using centers for disease control and prevention (CDC) growth charts for the pediatric population. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>z-score</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="109"/>
                <count group_id="O4" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="117"/>
                    <count group_id="O2" value="56"/>
                    <count group_id="O3" value="109"/>
                    <count group_id="O4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.04"/>
                    <measurement group_id="O2" value="-0.01" spread="0.06"/>
                    <measurement group_id="O3" value="0.14" spread="0.04"/>
                    <measurement group_id="O4" value="-0.02" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="114"/>
                    <count group_id="O2" value="53"/>
                    <count group_id="O3" value="105"/>
                    <count group_id="O4" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.04"/>
                    <measurement group_id="O2" value="0.04" spread="0.06"/>
                    <measurement group_id="O3" value="0.16" spread="0.04"/>
                    <measurement group_id="O4" value="0.08" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="112"/>
                    <count group_id="O2" value="53"/>
                    <count group_id="O3" value="101"/>
                    <count group_id="O4" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.04"/>
                    <measurement group_id="O2" value="0.08" spread="0.06"/>
                    <measurement group_id="O3" value="0.15" spread="0.04"/>
                    <measurement group_id="O4" value="0.07" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="110"/>
                    <count group_id="O2" value="49"/>
                    <count group_id="O3" value="100"/>
                    <count group_id="O4" value="56"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.04"/>
                    <measurement group_id="O2" value="0.08" spread="0.06"/>
                    <measurement group_id="O3" value="0.17" spread="0.04"/>
                    <measurement group_id="O4" value="0.1" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="100"/>
                    <count group_id="O2" value="46"/>
                    <count group_id="O3" value="100"/>
                    <count group_id="O4" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.04"/>
                    <measurement group_id="O2" value="0.13" spread="0.06"/>
                    <measurement group_id="O3" value="0.16" spread="0.04"/>
                    <measurement group_id="O4" value="0.14" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="95"/>
                    <count group_id="O2" value="46"/>
                    <count group_id="O3" value="97"/>
                    <count group_id="O4" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.04"/>
                    <measurement group_id="O2" value="0.13" spread="0.06"/>
                    <measurement group_id="O3" value="0.11" spread="0.04"/>
                    <measurement group_id="O4" value="0.12" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="91"/>
                    <count group_id="O2" value="45"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="44"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.04"/>
                    <measurement group_id="O2" value="0.16" spread="0.06"/>
                    <measurement group_id="O3" value="0.14" spread="0.04"/>
                    <measurement group_id="O4" value="0.13" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="85"/>
                    <count group_id="O2" value="45"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.04"/>
                    <measurement group_id="O2" value="0.12" spread="0.06"/>
                    <measurement group_id="O3" value="0.04" spread="0.04"/>
                    <measurement group_id="O4" value="0.08" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
        <time_frame>Baseline (Study 103/104/105), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
        <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received the same treatment in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4.</description>
          <population>FAS study 105 (NCT01931839) included all participants randomized in the Part A Treatment Cohort and dosed. Here, ‘Number of participants analyzed’ = those participants who were evaluable for this endpoint and ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>kilograms (kg)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="329"/>
                <count group_id="O2" value="178"/>
                <count group_id="O3" value="338"/>
                <count group_id="O4" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="328"/>
                    <count group_id="O2" value="178"/>
                    <count group_id="O3" value="338"/>
                    <count group_id="O4" value="175"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="2.6"/>
                    <measurement group_id="O2" value="-0.1" spread="1.8"/>
                    <measurement group_id="O3" value="1.3" spread="2.9"/>
                    <measurement group_id="O4" value="0.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="329"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="331"/>
                    <count group_id="O4" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="2.9"/>
                    <measurement group_id="O2" value="0.2" spread="2.1"/>
                    <measurement group_id="O3" value="1.5" spread="3.1"/>
                    <measurement group_id="O4" value="0.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="321"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="325"/>
                    <count group_id="O4" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="3.2"/>
                    <measurement group_id="O2" value="0.4" spread="2.6"/>
                    <measurement group_id="O3" value="1.6" spread="3.3"/>
                    <measurement group_id="O4" value="1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="312"/>
                    <count group_id="O2" value="169"/>
                    <count group_id="O3" value="319"/>
                    <count group_id="O4" value="165"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="3.5"/>
                    <measurement group_id="O2" value="0.6" spread="2.6"/>
                    <measurement group_id="O3" value="2" spread="3.6"/>
                    <measurement group_id="O4" value="1.2" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="304"/>
                    <count group_id="O2" value="165"/>
                    <count group_id="O3" value="315"/>
                    <count group_id="O4" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="3.8"/>
                    <measurement group_id="O2" value="1" spread="3.4"/>
                    <measurement group_id="O3" value="2.4" spread="3.8"/>
                    <measurement group_id="O4" value="1.9" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="299"/>
                    <count group_id="O2" value="162"/>
                    <count group_id="O3" value="307"/>
                    <count group_id="O4" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="4.2"/>
                    <measurement group_id="O2" value="1.3" spread="3.7"/>
                    <measurement group_id="O3" value="2.5" spread="4.3"/>
                    <measurement group_id="O4" value="2.1" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="296"/>
                    <count group_id="O2" value="158"/>
                    <count group_id="O3" value="298"/>
                    <count group_id="O4" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="4.6"/>
                    <measurement group_id="O2" value="1.7" spread="4.2"/>
                    <measurement group_id="O3" value="2.9" spread="4.6"/>
                    <measurement group_id="O4" value="2.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="287"/>
                    <count group_id="O2" value="152"/>
                    <count group_id="O3" value="289"/>
                    <count group_id="O4" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="4.9"/>
                    <measurement group_id="O2" value="1.7" spread="4.8"/>
                    <measurement group_id="O3" value="2.7" spread="4.9"/>
                    <measurement group_id="O4" value="2.3" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
        <description>Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
        <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
        <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received the same treatment in this VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Absolute Change From Baseline in Body Weight at Day 15, Week 8, 16, 24, 36, 48, 60 and 72</title>
          <description>Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7.</description>
          <population>FAS (study 105) included all participants randomized in the Part B Treatment Cohort and dosed. Here, ‘Number Analyzed’ = those participants who were evaluable at the specified time points for each arm, respectively.</population>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="55"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Absolute Change at Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="55"/>
                    <count group_id="O2" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.5"/>
                    <measurement group_id="O2" value="-0.1" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="54"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="2.3"/>
                    <measurement group_id="O2" value="0.4" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="2.8"/>
                    <measurement group_id="O2" value="0.6" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="37"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="2.6"/>
                    <measurement group_id="O2" value="0.4" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1.7"/>
                    <measurement group_id="O2" value="2.3" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 48</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="17"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="2"/>
                    <measurement group_id="O2" value="2.2" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="2.3"/>
                    <measurement group_id="O2" value="1.5" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Absolute Change at Week 72</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="13"/>
                    <count group_id="O2" value="15"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="2.3"/>
                    <measurement group_id="O2" value="1.1" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Time-to-First Pulmonary Exacerbation</title>
        <description>Time-to-first pulmonary exacerbation was analyzed using the Kaplan-Meier estimates. Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
        <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
        <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Time-to-First Pulmonary Exacerbation</title>
          <description>Time-to-first pulmonary exacerbation was analyzed using the Kaplan-Meier estimates. Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
          <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="368"/>
                <count group_id="O2" value="179"/>
                <count group_id="O3" value="369"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="364" lower_limit="99">Data for Q3 interquartile range could not be estimated due to limited number of events.</measurement>
                    <measurement group_id="O2" value="505" lower_limit="111">Data for Q3 interquartile range could not be estimated due to limited number of events.</measurement>
                    <measurement group_id="O3" value="481" lower_limit="132">Data for Q3 interquartile range could not be estimated due to limited number of events.</measurement>
                    <measurement group_id="O4" value="466" lower_limit="153">Data for Q3 interquartile range could not be estimated due to limited number of events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Percentage of Participants With at Least 1 Pulmonary Exacerbation</title>
        <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
        <time_frame>Baseline (Study 103/104) up to Week 100 (Study 105) for Arm 1 and 3 (Cumulative study period); Baseline (Study 105) up to Week 100 (Study 105) for Arm 2 and 4 (current study period)</time_frame>
        <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Percentage of Participants With at Least 1 Pulmonary Exacerbation</title>
          <description>Pulmonary exacerbation was defined as the treatment with new or changed antibiotic therapy (intravenous, inhaled, or oral) for greater than or equal to 4 sinopulmonary signs/symptoms. Analysis was performed for the Cumulative Study Period for Arm 1 and 3, and for the current study period (Study 105) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
          <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="368"/>
                <count group_id="O2" value="179"/>
                <count group_id="O3" value="369"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.7" lower_limit="59.8" upper_limit="69.6"/>
                    <measurement group_id="O2" value="53.6" lower_limit="46.3" upper_limit="60.9"/>
                    <measurement group_id="O3" value="59.9" lower_limit="54.9" upper_limit="64.9"/>
                    <measurement group_id="O4" value="55.7" lower_limit="48.3" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% and 10% relative change in percent predicted FEV1 from baseline were reported. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
        <time_frame>Baseline (Study 103/104/105); Day 15, Week 8, 16, 24, 36, 48, 60, 72, 84, 96 (Study 105)</time_frame>
        <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Part A - LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Part A - Placebo- LUM 600 mg qd/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
          <group group_id="O3">
            <title>Arm 3: Part A - LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949).</description>
          </group>
          <group group_id="O4">
            <title>Arm 4: Part A - Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 (NCT01931839) up to Week 96.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% and 10% relative change in percent predicted FEV1 from baseline were reported. Analysis was performed using baseline of the previous study VX12-809-103 (NCT01807923) and Study VX12-809-104 (NCT01807949) for Arm 1 and 3. Analysis was performed using baseline of the current study VX12-809-105 (NCT01931839) for Arm 2 and 4. As per planned analysis, endpoint evaluation included subjects from the parent study VX12-809-103 and VX12-809-104 as well for cumulative study period.</description>
          <population>FAS (Study 103/104) was used for Arm 1 and 3, and included all participants randomized in the previous studies and dosed. FAS (Study 105) was used for Arm 2 and 4, and included all participants randomized in the Part A Treatment Cohort and dosed in current study 105.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="368"/>
                <count group_id="O2" value="179"/>
                <count group_id="O3" value="369"/>
                <count group_id="O4" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 15: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.4" lower_limit="34.4" upper_limit="44.4"/>
                    <measurement group_id="O2" value="42.5" lower_limit="35.2" upper_limit="49.7"/>
                    <measurement group_id="O3" value="40.9" lower_limit="35.9" upper_limit="45.9"/>
                    <measurement group_id="O4" value="42.6" lower_limit="35.3" upper_limit="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" lower_limit="20.6" upper_limit="29.4"/>
                    <measurement group_id="O2" value="26.8" lower_limit="20.3" upper_limit="33.3"/>
                    <measurement group_id="O3" value="24.7" lower_limit="20.3" upper_limit="29.1"/>
                    <measurement group_id="O4" value="26.7" lower_limit="20.2" upper_limit="33.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.7" lower_limit="34.7" upper_limit="44.7"/>
                    <measurement group_id="O2" value="38" lower_limit="30.9" upper_limit="45.1"/>
                    <measurement group_id="O3" value="39.3" lower_limit="34.3" upper_limit="44.3"/>
                    <measurement group_id="O4" value="48.9" lower_limit="41.5" upper_limit="56.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9" lower_limit="22.4" upper_limit="31.4"/>
                    <measurement group_id="O2" value="23.5" lower_limit="17.3" upper_limit="29.7"/>
                    <measurement group_id="O3" value="26.6" lower_limit="22.1" upper_limit="31.1"/>
                    <measurement group_id="O4" value="35.8" lower_limit="28.7" upper_limit="42.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 16: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.2" lower_limit="32.3" upper_limit="42.2"/>
                    <measurement group_id="O2" value="36.9" lower_limit="29.8" upper_limit="43.9"/>
                    <measurement group_id="O3" value="36.9" lower_limit="31.9" upper_limit="41.8"/>
                    <measurement group_id="O4" value="46.6" lower_limit="39.2" upper_limit="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 16: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.5" lower_limit="21.1" upper_limit="30"/>
                    <measurement group_id="O2" value="25.1" lower_limit="18.8" upper_limit="31.5"/>
                    <measurement group_id="O3" value="26.3" lower_limit="21.8" upper_limit="30.8"/>
                    <measurement group_id="O4" value="28.4" lower_limit="21.7" upper_limit="35.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.6" lower_limit="30.7" upper_limit="40.5"/>
                    <measurement group_id="O2" value="38" lower_limit="30.9" upper_limit="45.1"/>
                    <measurement group_id="O3" value="33.6" lower_limit="28.8" upper_limit="38.4"/>
                    <measurement group_id="O4" value="42.6" lower_limit="35.3" upper_limit="49.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5" lower_limit="20.1" upper_limit="28.8"/>
                    <measurement group_id="O2" value="21.8" lower_limit="15.7" upper_limit="27.8"/>
                    <measurement group_id="O3" value="22.5" lower_limit="18.2" upper_limit="26.8"/>
                    <measurement group_id="O4" value="32.4" lower_limit="25.5" upper_limit="39.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 36: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.3" lower_limit="30.4" upper_limit="40.2"/>
                    <measurement group_id="O2" value="32.4" lower_limit="25.5" upper_limit="39.3"/>
                    <measurement group_id="O3" value="31.7" lower_limit="27" upper_limit="36.5"/>
                    <measurement group_id="O4" value="38.6" lower_limit="31.4" upper_limit="45.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 36: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.4" lower_limit="19" upper_limit="27.7"/>
                    <measurement group_id="O2" value="22.9" lower_limit="16.7" upper_limit="29.1"/>
                    <measurement group_id="O3" value="22.2" lower_limit="18" upper_limit="26.5"/>
                    <measurement group_id="O4" value="27.3" lower_limit="20.7" upper_limit="33.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 48: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.2" lower_limit="25.5" upper_limit="34.9"/>
                    <measurement group_id="O2" value="32.4" lower_limit="25.5" upper_limit="39.3"/>
                    <measurement group_id="O3" value="30.9" lower_limit="26.2" upper_limit="35.6"/>
                    <measurement group_id="O4" value="36.4" lower_limit="29.3" upper_limit="43.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 48: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" lower_limit="17.5" upper_limit="26"/>
                    <measurement group_id="O2" value="21.8" lower_limit="15.7" upper_limit="27.8"/>
                    <measurement group_id="O3" value="21.4" lower_limit="17.2" upper_limit="25.6"/>
                    <measurement group_id="O4" value="19.9" lower_limit="14" upper_limit="25.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 60: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.4" lower_limit="25.7" upper_limit="35.1"/>
                    <measurement group_id="O2" value="32.4" lower_limit="25.5" upper_limit="39.3"/>
                    <measurement group_id="O3" value="29.3" lower_limit="24.6" upper_limit="33.9"/>
                    <measurement group_id="O4" value="38.6" lower_limit="31.4" upper_limit="45.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 60: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.4" lower_limit="16.3" upper_limit="24.5"/>
                    <measurement group_id="O2" value="25.1" lower_limit="18.8" upper_limit="31.5"/>
                    <measurement group_id="O3" value="19.2" lower_limit="15.2" upper_limit="23.3"/>
                    <measurement group_id="O4" value="24.4" lower_limit="18.1" upper_limit="30.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 72: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.3" lower_limit="24.7" upper_limit="34"/>
                    <measurement group_id="O2" value="34.6" lower_limit="27.7" upper_limit="41.6"/>
                    <measurement group_id="O3" value="25.5" lower_limit="21" upper_limit="29.9"/>
                    <measurement group_id="O4" value="33" lower_limit="26" upper_limit="39.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 72: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.2" lower_limit="14.3" upper_limit="22.1"/>
                    <measurement group_id="O2" value="22.3" lower_limit="16.2" upper_limit="28.4"/>
                    <measurement group_id="O3" value="18.2" lower_limit="14.2" upper_limit="22.1"/>
                    <measurement group_id="O4" value="23.3" lower_limit="17.1" upper_limit="29.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 84: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1" lower_limit="18.8" upper_limit="27.4"/>
                    <measurement group_id="O2" value="28.5" lower_limit="21.9" upper_limit="35.1"/>
                    <measurement group_id="O3" value="23.3" lower_limit="19" upper_limit="27.6"/>
                    <measurement group_id="O4" value="26.1" lower_limit="19.6" upper_limit="32.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 84: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" lower_limit="11.3" upper_limit="18.6"/>
                    <measurement group_id="O2" value="21.2" lower_limit="15.2" upper_limit="27.2"/>
                    <measurement group_id="O3" value="15.7" lower_limit="12" upper_limit="19.4"/>
                    <measurement group_id="O4" value="19.9" lower_limit="14" upper_limit="25.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 96: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" lower_limit="11.8" upper_limit="19.2"/>
                    <measurement group_id="O2" value="14.5" lower_limit="9.4" upper_limit="19.7"/>
                    <measurement group_id="O3" value="13.8" lower_limit="10.3" upper_limit="17.3"/>
                    <measurement group_id="O4" value="15.3" lower_limit="10" upper_limit="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 96: &gt;=10% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" lower_limit="5.8" upper_limit="11.6"/>
                    <measurement group_id="O2" value="10.1" lower_limit="5.7" upper_limit="14.5"/>
                    <measurement group_id="O3" value="10.3" lower_limit="7.2" upper_limit="13.4"/>
                    <measurement group_id="O4" value="9.1" lower_limit="4.8" upper_limit="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part B Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</title>
        <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% relative change in percent predicted FEV1 from Baseline were reported. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7. As per planned analysis, endpoint evaluation included subjects from the parent study VX09-809-102 as well.</description>
        <time_frame>Baseline (Study 102), Day 15, Week 8, 16, 24, 36, 48, 60, 72 (Study 105)</time_frame>
        <population>FAS (Study 102) was used for Arm 6 and 7, and included all participants randomized in the cohort 4 of study 102 and dosed.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 6: Part B LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102 (NCT01225211).</description>
          </group>
          <group group_id="O2">
            <title>Arm 7: Part B Placebo- LUM 400 mg q12h/ IVA 250 mg q12h</title>
            <description>Participants who were randomized to placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102 (NCT01225211).</description>
          </group>
        </group_list>
        <measure>
          <title>Part B Treatment Cohort: Percentage of Participants With Response Based on Relative Change in Percent Predicted FEV1 From Baseline</title>
          <description>FEV1 is the volume of air that can forcibly be blown out in one second, after full inspiration. Hankinson and Wang standards were used to calculate percent predicted FEV1 (for age, gender, race, and height). Percentage of participants with at least 5% relative change in percent predicted FEV1 from Baseline were reported. Analysis was performed using baseline of Cohort 4 of previous study VX09-809-102 (NCT01225211) for Arm 6 and 7. As per planned analysis, endpoint evaluation included subjects from the parent study VX09-809-102 as well.</description>
          <population>FAS (Study 102) was used for Arm 6 and 7, and included all participants randomized in the cohort 4 of study 102 and dosed.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="62"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 15: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="10.8" upper_limit="31.1"/>
                    <measurement group_id="O2" value="12.7" lower_limit="4.5" upper_limit="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" lower_limit="3.4" upper_limit="19.2"/>
                    <measurement group_id="O2" value="19" lower_limit="9.4" upper_limit="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 16: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.4" lower_limit="9.5" upper_limit="29.2"/>
                    <measurement group_id="O2" value="15.9" lower_limit="6.8" upper_limit="24.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 24: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.9" lower_limit="4.6" upper_limit="21.2"/>
                    <measurement group_id="O2" value="12.7" lower_limit="4.5" upper_limit="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 36: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="0.3" upper_limit="12.6"/>
                    <measurement group_id="O2" value="6.3" lower_limit="0.3" upper_limit="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 48: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="0.3" upper_limit="12.6"/>
                    <measurement group_id="O2" value="4.8" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 60: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="0.3" upper_limit="12.6"/>
                    <measurement group_id="O2" value="6.3" lower_limit="0.3" upper_limit="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 72: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" lower_limit="0" upper_limit="7.6"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 84: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" lower_limit="0" upper_limit="4.7"/>
                    <measurement group_id="O2" value="1.6" lower_limit="0" upper_limit="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 96: &gt;=5% Change</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="0"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Part A Observation Cohort: Number of Participants With Serious Adverse Events (SAEs)</title>
        <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after the informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event.</description>
        <time_frame>up to 2 years</time_frame>
        <population>Safety Set (study 105) included all participants who were enrolled in Part A Observation Cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 5: Part A Observational Cohort</title>
            <description>Participants who received either LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening or LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening or placebo matched to LUM and IVA in the morning and evening, in the previous study VX12-809-103 (NCT01807923) or VX12-809-104 (NCT01807949), were observed (did not receive study drug) in this study VX12-809-105 (NCT01931839) for up to 2 years.</description>
          </group>
        </group_list>
        <measure>
          <title>Part A Observation Cohort: Number of Participants With Serious Adverse Events (SAEs)</title>
          <description>AE: as any untoward medical occurrence in a participant during the study; the event does not necessarily have a causal relationship with the treatment. This includes any newly occurring event or previous condition that has increased in severity or frequency after the informed consent form is signed. AE includes serious as well as non-serious AEs. SAE (subset of AE): medical event or condition, which falls into any of the following categories, regardless of its relationship to the study drug: death, life threatening adverse experience, In-patient hospitalization/prolongation of hospitalization, persistent/significant disability or incapacity, congenital anomaly/birth defect, important medical event.</description>
          <population>Safety Set (study 105) included all participants who were enrolled in Part A Observation Cohort.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Non-SAEs were not collected for Arm 5: Part A Observational Cohort. Only SAEs were collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm 1 Part A: LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received lumacaftor (LUM, VX-809) 600 milligram (mg) plus ivacaftor (IVA, VX-770) 250 mg fixed-dose combination (FDC) tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening, in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="E2">
          <title>Arm 2 Part A: Placebo - LUM 600 mg qd/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="E3">
          <title>Arm 3 Part A: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in the previous study VX12-809-103 or VX12-809-104, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="E4">
          <title>Arm 4 Part A: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in the previous study VX12-809-103 or VX12-809-104, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="E5">
          <title>Arm 5 Part A: Observational Cohort</title>
          <description>Participants who received either LUM 600 mg plus IVA 250 mg FDC tablet orally in the morning and IVA 250 mg film-coated tablet orally in the evening OR LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening OR placebo matched to LUM and IVA in the morning and evening, in the previous study VX12-809-103 or VX12-809-104, were observed (did not receive study drug) in this study VX12-809-105 for up to 2 years.</description>
        </group>
        <group group_id="E6">
          <title>Arm 6 Part B: LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in Cohort 4 of the previous study VX09-809-102, received the same treatment in this study VX12-809-105 up to Week 96.</description>
        </group>
        <group group_id="E7">
          <title>Arm 7 Part B: Placebo - LUM 400 mg q12h/ IVA 250 mg q12h</title>
          <description>Participants who received placebo matched to LUM and IVA tablet in Cohort 4 of the previous study VX09-809-102, received LUM 400 mg plus IVA 250 mg FDC tablet orally in the morning and evening in this study VX12-809-105 up to Week 96.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (19.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="156" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="77" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="143" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="89" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="21" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Cystic fibrosis related diabetes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystic fibrosis pancreatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Distal intestinal obstruction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal wall haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Medical device site thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Serum sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Type IV hypersensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infective pulmonary exacerbation of cystic fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="111" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="59" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="15" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="15" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary aspergillosis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatitis E</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mycobacterium abscessus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Periorbital abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peritonsillar abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Pulmonary function test decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bacterial test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Forced expiratory volume decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gammaglutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza B virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza A virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Juvenile myoclonic epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vocal cord paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adjustment disorder with depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiration abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary bulla</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (19.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="328" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="177" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="332" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="173" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="52" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="57" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eosinophilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Splenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bone marrow oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoconcentration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased tendency to bruise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Macrocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Left ventricular hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroglossal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystic fibrosis related diabetes</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystic fibrosis hepatic disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystic fibrosis lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Naevus flammeus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cerumen impaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoacusis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Middle ear effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Motion sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ototoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Growth hormone deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Androgen deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cushing's syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="41" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="33" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Distal intestinal obstruction syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dental discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lip swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post-tussive vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Steatorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth impacted</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aphthous ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bowel movement irregularity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breath odour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paraesthesia oral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Varices oesophageal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abdominal tenderness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faecal volume decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faecal volume increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Faeces soft</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastric mucosal hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrointestinal motility disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingival recession</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingivitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glossitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glossodynia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemorrhoids thrombosed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intussusception</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malabsorption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malpositioned teeth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mucous stools</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oesophageal irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oesophageal mucosal hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oesophageal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral mucosal blistering</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral papule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pancreatic insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Reflux gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Salivary hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth delamination</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Micturition urgency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="47" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="31" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="36" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Application site vesicles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Catheter site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Exercise tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sensation of foreign body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vessel puncture site bruise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Application site irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Catheter site rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Drug intolerance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hunger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infusion site bruising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infusion site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Medical device pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Medical device site ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Temperature intolerance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaccination site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vessel puncture site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vessel puncture site phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infusion site inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Medical device site extravasation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adjustment disorder with anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergy to arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergy to animal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergy to arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>House dust allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Immunisation reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mycotic allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Reaction to food additive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Serum sickness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Smoke sensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infective pulmonary exacerbation of cystic fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="185" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="173" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="91" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="20" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="66" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="49" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="29" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="47" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="24" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary aspergillosis allergic</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bacterial disease carrier</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary aspergillosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Herpes dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinusitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tinea infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hand-foot-and-mouth disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infectious mononucleosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mycobacterial disease carrier</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Superinfection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastrointestinal viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mycobacterium abscessus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oropharyngitis fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otitis externa fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acne pustular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adenoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Angular cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Atypical mycobacterial lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Atypical mycobacterial pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bacterial vaginosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchitis fungal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Conjunctivitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Erythema infectiosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Furuncle</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital herpes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Genital infection fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemophilus infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oral bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Overgrowth bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Overgrowth fungal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Papilloma viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pseudomonas bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pseudomonas infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulpitis dental</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Salpingo-oophoritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection fungal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Small intestinal bacterial overgrowth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sputum purulent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Trichomoniasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary tract infection enterococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Periorbital haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sports injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Superficial injury of eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Accidental exposure to product</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Animal scratch</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Avulsion fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Confusion postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Corneal abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ear injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Exposure to toxic agent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Heat stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Infusion related reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lip injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neck injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peripheral nerve injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus barotrauma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Splinter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stoma site ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Pulmonary function test decreased</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="29" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Forced expiratory volume decreased</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="28" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bacterial test positive</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="30" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood alkaline phosphatase increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fungal test positive</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin D decreased</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>White blood cell count increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Atypical mycobacterium test positive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza A virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neutrophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Clostridium test positive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oxygen saturation decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>White blood cells urine positive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Activated partial thromboplastin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood bicarbonate decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood immunoglobulin E increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Crystal urine present</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Protein urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Staphylococcus test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood calcium increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood thyroid stimulating hormone increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breath sounds abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eosinophil count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Forced vital capacity decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glucose urine present</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glycosylated haemoglobin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Monocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pseudomonas test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood lactate dehydrogenase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Candida test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glucose tolerance test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Human rhinovirus test positive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza B virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood albumin decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood immunoglobulin G increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood iron decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Helicobacter test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Influenza virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lymphocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Reticulocyte percentage increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sputum abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Platelet count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Prothrombin time prolonged</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aspergillus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood androstenedione increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood cholesterol increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood cortisol decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood creatine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood glucose fluctuation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood magnesium increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood phosphorus decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood phosphorus increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood sodium increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood testosterone decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood testosterone increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Burkholderia test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Citrobacter test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Computerised tomogram thorax abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Coronavirus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dehydroepiandrosterone increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Electrocardiogram PR shortened</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Electrocardiogram ST segment elevation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Electrocardiogram abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epstein-Barr virus antibody positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Escherichia test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Grip strength decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoglobin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Human metapneumovirus test positive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Human papilloma virus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mean cell volume increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myoglobin blood increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Precancerous cells present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Red blood cells urine positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Reticulocyte count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rubulavirus test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ultrasound liver abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urine analysis abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urine bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urine ketone body present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Viral test positive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin A decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin B12 decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin E decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alcohol intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypovitaminosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Selenium deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin A deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin E deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin K deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyponatraemic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Underweight</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vitamin B12 deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Weight gain poor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Osteopenia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Medial tibial stress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Temporomandibular joint syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Juvenile idiopathic arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Myalgia intercostal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tendon pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Torticollis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Coccydynia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intervertebral disc annular tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Mastication disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Muscle oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neurofibroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Seborrhoeic keratosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus headache</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Anosmia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Circadian rhythm sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Restless legs syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ageusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Aphonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Coordination abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyposmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Olfactory nerve disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Device leakage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Attention deficit/hyperactivity disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adjustment disorder with depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Decreased interest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Disturbance in social behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Encopresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Food aversion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hallucination, visual</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Listless</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Obsessive-compulsive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Somnambulism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chromaturia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Glycosuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypernatriuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypocitraturia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pyelocaliectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Renal tubular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial nephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urine abnormality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Abnormal withdrawal bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Polycystic ovaries</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Breast tenderness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acquired hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Adnexa uteri mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bartholin's cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ovarian cyst ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ovarian hyperfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Polymenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus genital</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Testicular cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Testicular pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vaginal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vulvovaginal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="167" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="145" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="82" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="18" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sputum increased</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="79" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="37" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="18" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="68" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="29" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="52" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="53" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="36" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiration abnormal</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="25" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="21" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="37" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paranasal sinus hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rales</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sputum discoloured</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased viscosity of bronchial secretion</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased bronchial secretion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Painful respiration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Throat irritation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal discharge discolouration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paranasal sinus discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nocturnal dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Oropharyngeal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhinalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchial obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchial secretion retention</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased upper airway secretion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal mucosal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sputum retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal dryness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngeal erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumothorax spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rhonchi</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acquired diaphragmatic eventration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergic cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Allergic respiratory disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchial irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Bronchostenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypopnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Increased viscosity of upper respiratory secretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung consolidation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Lung hyperinflation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Nasal turbinate hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Paranasal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pharyngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pleural fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumomediastinum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary arterial hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary bulla</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Reflux laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract inflammation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Respiratory tract irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Throat tightness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tonsillolith</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tracheal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Tracheal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Red man syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus allergic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pain of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Photosensitivity reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis acneiform</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hand dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hyperkeratosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin mass</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin warm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Solar dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Acne cystic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eczema asteatotic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Eczema nummular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Fixed drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypersensitivity vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Keratosis pilaris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Madarosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Onycholysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Palmar-plantar erythrodysaesthesia syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Purpura senile</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash morbilliform</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Rosacea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Scar pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Skin wrinkling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Urticarial vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Menopause</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Ethmoid sinus surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Wisdom teeth removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Peripheral coldness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Vasodilatation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="178"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="340"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="55"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Analysis using baseline values of the current study 105 (NCT01931839) was not performed for Part B Treatment Cohort.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Vertex Pharmaceuticals Incorporated</organization>
      <phone>617-341-6777</phone>
      <email>medicalinfo@vrtx.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

